<DOC>
	<DOCNO>NCT01462344</DOCNO>
	<brief_summary>The purpose study ass whether risk serious asthma-related event ( asthma-related hospitalization , endotracheal intubation , death ) child 4-11 year old take inhaled fluticasone propionate/salmeterol combination take inhaled fluticasone propionate alone .</brief_summary>
	<brief_title>6-month Safety Benefit Study ADVAIR Children 4-11 Years Old</brief_title>
	<detailed_description>Progress Enrollment , Updated Annually : This study complete final clinical study report submit FDA May 2016 . This final update , study complete .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>1 . Consent participate study 2 . Age 411 year old 3 . Male eligible female Female subject enrol pregnant , lactating plan become pregnant time study participation 4 . Asthma diagnosis least 6 month 5 . Ability answer question regard asthma control use meter dose inhaler DISKUS 6 . A history clinical varicella infection recipient varicella vaccine country product label include warn regard serious chickenpox infection patient use corticosteroid . 7 . History least occurrence asthma exacerbation within prior 12 month 8 . Currently treat asthma change asthma therapy last 4 week ( Eligible subject include : subject use shortacting betaagonist , leukotriene receptor antagonist , theophylline , cromolyn whose asthma wellcontrolled ; subject lowdose ICS monotherapy whose asthma wellcontrolled ; subject lowdose ICS one adjunctive therapy whose asthma either control wellcontrolled asthma ; subject mediumdose ICS monotherapy whose asthma either control wellcontrolled ; subject mediumdose ICS one adjunctive therapy whose asthma wellcontrolled ) 1 . History lifethreatening asthma 2 . Unstable asthma 3 . Current use highdose ICS ICS/LABA therapy treat asthma symptom 4 . Concurrent respiratory disease : Current evidence pneumonia , pneumothorax , atelectasis , pulmonary fibrotic disease , allergic bronchopulmonary aspergillosis , cystic fibrosis , bronchopulmonary dysplasia , severe respiratory abnormality asthma . 5 . Respiratory infection 6 . Subjects exerciseinduced asthma 7 . An asthma exacerbation within last 4 week 4 separate exacerbation last 12 month 8 . Hospitalization asthma within 4 week 2 hospitalization within last 12 month 9 . Other current evidence clinically significant uncontrolled disease/conditions body organ system 10 . Neurological psychiatric disease history drug alcohol abuse subject his/her guardian opinion investigator could interfere subject 's proper completion protocol requirement 11 . Participation interventional study use investigational drug disease state within last 30 day 12 . Any adverse reaction include immediate delay hypersensitivity betaagonist , sympathomimetic drug , intranasal , inhale , systemic corticosteroid therapy , vehicle contain within medication 13 . Severe hypersensitivity cow 's milk proteins 14 . Administration prescription counter medication would significantly affect course asthma , interact sympathomimetic amine : antiIgE ( omalizumab ) , anticonvulsant ( barbiturate , hydantoin , carbamazepine ) ; polycyclic antidepressant , betaadrenergic blocker ; phenothiazine , monoamine oxidase inhibitor , diuretic 15 . Potent cytochrome P450 3A4 ( CYP3A4 ) inhibitor within last 4 week ( e.g. , ritonavir , ketoconazole , itraconzole ) 16 . Affiliation investigator 's site , include immediate family member participate investigator , subinvestigator , study coordinator , employee participate investigator . 17 . A Child Care ( CiC ) child place control protection agency , organisation , institution entity court , government government body , act accordance power confer law regulation .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>pediatric</keyword>
	<keyword>ADVAIR</keyword>
	<keyword>FLOVENT</keyword>
	<keyword>asthma</keyword>
</DOC>